Intraarterial_cisplatin_in_the_management_of_stage_IIB_osteosarcoma_in_the_pediatric_and_adolescent_age_group._Sixty_patients_with_extremity_osteosarcoma_were_treated_with_intraarterial_cisplatin._This_was_followed_by_surgical_resection_(amputation_or_limb_salvage)_and_postoperative_adjuvant_chemotherapy_utilizing_two_different_protocols._Seventy-five_percent_of_patients_achieved_an_initial_response._Overall_disease-free_survival_was_58%._The_number_of_patients_treated_with_limb-salvage_surgery_gradually_increased_to_the_extent_that_80%_of_newly-registered_patients_achieved_a_response_and_were_subjected_to_limb_salvage._Disease-free_survival_was_48%_in_amputation_and_68%_in_limb_salvage._The_only_factors_found_to_have_prognostic_significance_in_determining_disease-free_survival_were_extent_of_tumor_destruction_induced_by_preoperative_chemotherapy_and_tumor_size.